Perbak Capital Partners’s Tenet Healthcare THC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-7,028
Closed -$887K 220
2024
Q4
$887K Buy
7,028
+766
+12% +$114K 0.47% 50
2024
Q3
$1.04M Sell
6,262
-14,705
-70% -$2.22M 0.73% 24
2024
Q2
$2.79M Buy
+20,967
New +$2.52M 0.82% 30

Other funds holding THC

Perbak Capital Partners's THC Position: Q1 2025 in Review

Perbak Capital Partners sold out of Tenet Healthcare (THC) in Q1 2025, closing a stake of 7,028 shares — an estimated $887K sold.

Perbak Capital Partners first reported a position in THC in Q2 2024 and held it in 3 quarters. The position peaked at $2.79M in Q2 2024. 566 funds tracked by Wall St. Rank hold THC as of Q1 2025.

  • Perbak Capital Partners reported no remaining Tenet Healthcare position as of Q1 2025 after selling out during the quarter.
  • Perbak Capital Partners sold 7,028 Tenet Healthcare shares in Q1 2025, an estimated $887K.
  • Perbak Capital Partners first reported a position in Tenet Healthcare in Q2 2024 and held it in 3 quarters.
  • Perbak Capital Partners's Tenet Healthcare position peaked at $2.79M in Q2 2024.
  • 566 funds tracked by Wall St. Rank held Tenet Healthcare as of Q1 2025.

Based on Perbak Capital Partners's 13F filing for Q1 2025, filed 15 May 2025.